[7] Cervarix also contains AS04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time.

[9] HPV is a virus, usually transmitted sexually, which can cause cervical cancer in a small percentage of those women genital infected.

[citation needed] In common with some other prefilled syringe vaccination products, the tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber that may cause allergic reactions in latex sensitive individuals.

L1 protein is in the form of non-infectious virus-like particles (VLPs) produced by recombinant DNA technology using a Baculovirus expression system which uses High Five Rix4446 cells derived from the insect Trichoplusia ni.

[12] The research findings that pioneered the development of the vaccine began in 1991 by The University of Queensland investigators Jian Zhou and Ian Frazer in Australia .

Researchers at UQ found a way to form non-infectious virus-like particles (VLP), which could also strongly activate the immune system.

[20] In the United Kingdom it was included in the national vaccination programme for teenage and pre-teenage girls aged 12–13 and 17–18 from September 2008 to August 2012.